3.8 Review

ATF2 on the double - activating transcription factor and DNA damage response protein

Journal

PIGMENT CELL RESEARCH
Volume 20, Issue 6, Pages 498-506

Publisher

BLACKWELL PUBLISHING
DOI: 10.1111/j.1600-0749.2007.00414.x

Keywords

ATF2; transcription; DNA damage; stress response; hypoxia; skin cancer; melanoma

Funding

  1. NCI NIH HHS [R01 CA059908-09, R01 CA099961, R01 CA051995, CA051995, R01 CA099961-03, R01 CA051995-13, CA099961, R01 CA059908] Funding Source: Medline

Ask authors/readers for more resources

Signal transduction pathways play a key role in the regulation of key cellular processes, including survival and death. Growing evidence points to changes in signaling pathway that occur during skin tumor development and progression. Such changes impact the activity of downstream substrates, including transcription factors. The activating transcription factor 2 (ATF2) has been implicated in malignant and non-malignant skin tumor developments. ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. Here, we summarize our present understanding of ATF2 regulation, function and contribution to malignant and non-malignant skin tumor development.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available